This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Dextrose 20% Injection USP (2016-03-02)

Starting date:
March 2, 2016
Posting date:
March 17, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-57512

Affected Products

Dextrose 20% Injection USP

Reason

Recall due to a potential contact with foreign substance during manufacturing.

Depth of distribution

Hospitals (including Pharmacies), Wholesalers

Affected products

Dextrose 20% Injection USP

DIN, NPN, DIN-HIM
DIN 00037966
Dosage form

Solution

Strength

Dextrose 200 mg/mL

Lot or serial number
  • 49075JT
  • 52113JT
Companies
Recalling Firm
Hospira Healthcare Corporation
2600 Alfred-Nobel Bvld, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
2600 Alfred-Nobel Bvld, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA

Date modified: